These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8466539)

  • 41. X-ray structure of a tethered dimer for HIV-1 protease.
    Bhat TN; Baldwin ET; Liu B; Cheng YS; Erickson JW
    Adv Exp Med Biol; 1995; 362():439-44. PubMed ID: 8540354
    [No Abstract]   [Full Text] [Related]  

  • 42. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The carboxyl side chain of glutamate 681 interacts with a chloride binding modifier site that allosterically modulates the dimeric conformational state of band 3 (AE1). Implications for the mechanism of anion/proton cotransport.
    Salhany JM; Sloan RL; Cordes KS
    Biochemistry; 2003 Feb; 42(6):1589-602. PubMed ID: 12578372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activities of precursor and tethered dimer forms of HIV proteinase.
    Phylip LH; Griffiths JT; Mills JS; Graves MC; Dunn BM; Kay J
    Adv Exp Med Biol; 1995; 362():467-72. PubMed ID: 8540359
    [No Abstract]   [Full Text] [Related]  

  • 46. Peptidomimetic inhibitors complexed with HIV-1 protease: crystallisation for X-ray diffraction studies.
    Dohnálek J; Hasek J; Brynda J; Fábry M; Sedlácek J; Konvalinka J; Hradilek M; Soucek M; Adams MJ; Naylor CE
    Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():9-11. PubMed ID: 9789742
    [No Abstract]   [Full Text] [Related]  

  • 47. Triterpenes as potential dimerization inhibitors of HIV-1 protease.
    Quéré L; Wenger T; Schramm HJ
    Biochem Biophys Res Commun; 1996 Oct; 227(2):484-8. PubMed ID: 8967903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Time-resolved fluorescence anisotropy of HIV-1 protease inhibitor complexes correlates with inhibitory activity.
    Kungl AJ; Visser NV; van Hoek A; Visser AJ; Billich A; Schilk A; Gstach H; Auer M
    Biochemistry; 1998 Mar; 37(9):2778-86. PubMed ID: 9485428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.
    Muzammil S; Ross P; Freire E
    Biochemistry; 2003 Jan; 42(3):631-8. PubMed ID: 12534275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activity and dimerization of human immunodeficiency virus protease as a function of solvent composition and enzyme concentration.
    Jordan SP; Zugay J; Darke PL; Kuo LC
    J Biol Chem; 1992 Oct; 267(28):20028-32. PubMed ID: 1400318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemical synthesis of the aspartic proteinase from human immunodeficiency virus (HIV).
    Hoeprich PD
    Methods Mol Biol; 1994; 36():287-304. PubMed ID: 7697114
    [No Abstract]   [Full Text] [Related]  

  • 52. Improved rearrangement of the integrated Michaelis-Menten equation for calculating in vivo kinetics of transport and metabolism.
    Russell RW; Drane JW
    J Dairy Sci; 1992 Dec; 75(12):3455-64. PubMed ID: 1474212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association-dissociation of the flavoprotein hog kidney D-amino acid oxidase. Determination of the monomer-dimer equilibrium constant and the energetics of subunit association.
    Horiike K; Shiga K; Nishina Y; Isomoto A; Yamano T
    J Biochem; 1977 Nov; 82(5):1247-55. PubMed ID: 22539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Kinetic behavior of slowly equilibrating association-dissociation enzyme systems].
    Kurganov BI; Dorozhko AI; Kagan ZS; Iakovlev VA
    Mol Biol (Mosk); 1975; 9(4):533-42. PubMed ID: 1214796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of specific peptide substrates for HIV-1 proteinase.
    Handa BK; Kay C
    Int J Pept Protein Res; 1992 Nov; 40(5):363-9. PubMed ID: 1483830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fixed-point methods for computing the equilibrium composition of complex biochemical mixtures.
    Kuzmic P
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):571-5. PubMed ID: 9531499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assay of HIV-1 proteinase: a colorimetric method using small peptide substrates.
    Broadhurst AV; Roberts NA; Ritchie AJ; Handa BK; Kay C
    Anal Biochem; 1991 Mar; 193(2):280-6. PubMed ID: 1872473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations.
    Burrows SD; Doyle ML; Murphy KP; Franklin SG; White JR; Brooks I; McNulty DE; Scott MO; Knutson JR; Porter D
    Biochemistry; 1994 Nov; 33(43):12741-5. PubMed ID: 7947677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of dimerization of the variable fragment of the Bence-Jones protein Au.
    Maeda H; Engel J; Schramm HJ
    Eur J Biochem; 1976 Oct; 69(1):133-9. PubMed ID: 991852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The dimerization of ferrihaems. II. Equilibrium and kinetic studies of mesoferrihaem dimerization.
    Brown SB; Hatzikonstantinou H
    Biochim Biophys Acta; 1978 Mar; 539(3):352-63. PubMed ID: 24479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.